Overview

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD

Status:
Unknown status

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

To assess the pharmacokinetics of a single dose of Aptensio XR® (methylphenidate hydrochloride extended-release) capsules under fed conditions in male or female children 4 to under 6 years of age with ADHD.

Phase:

Phase 4

Details

Lead Sponsor:

Rhodes Pharmaceuticals, L.P.

Treatments:

Methylphenidate